wolf casino login
F.N.B. Corporation Prices $500 Million Senior Notes Offering
What happens when 'The Simpsons' join 'Monday Night Football'? Find out during Bengals-CowboysJeff Bezos Says He Is “Proud” of Decision to End Endorsements at Washington Post, “Very Optimistic” About Second Trump Term
Book a ‘love letter’ to historic churchExternal Affairs Minister S Jaishankar on Saturday reacted to President-elect Donald Trump's threat to impose 100 per cent tariffs on BRICS nations, stating that India has "no interest" in weakning the US dollar. Speaking at the Doha Forum on Saturday, Jaishankar reflected on the positive relationship India had with the first Trump administration, highlighting the restart of the QUAD under Trump's presidency. "We had a good relationship, a very solid relationship with the first Trump administration, yes there were some issues mostly trade related issues, but there were a whole lot of issues on which Trump was very international, and i remind people that it was actually under Trump that the QUAD was restarted," he said. ALSO READ: Hyderabad: Ambulance Hijacked And Stolen, Thief Arrested After 100 Km Chase; Police Officer Injured He also noted the personal connection between Prime Minister Narendra Modi and President-elect Trump, which has contributed to the strong bilateral ties between the two countries. "There a personal relation between PM Modi and Trump...Where the BRICS remarks was concerened. We've always said that India has never been for de-dolarisation, right now there is no proposal to have a BRICS currency. The BRICS do discuss financial transrations...US is our largest trade partner, we have no interest in weakning the dollar at all," he added. Jaishankar was adressing the 22nd edition of the Doha Forum panel on 'Conflict Resolution in a New Era' where Qatar Foreign Minister Sheikh Mohammed bin Abdulrahman bin Jassim Al Thani and Norway Foreign Minister, Espen Barth Eide were also present. EAM Jaishankar is on a official visit to Qatar and Bahrain from December 6-9. In Bahrain, he will co-chair the 4th India-Bahrain High Joint Commission (HJC) with Foreign Minister of Bahrain; Abdullatif bin Rashid Al Zayani. EAM will also participate in the 20th edition of IISS Manama Dialogue in Bahrain on December 8. Earlier on September 9, EAM Jaishankar held a meeting with Qatar's Prime Minister Mohammed bin Abdulrahman Al Thani in Saudi Arabia. The two leaders discussed taking forward bilateral ties. Sharing details regarding his meeting with Qatar PM, Jaishankar stated, "Began the day with a good meeting with PM & FM of Qatar @MBA_AlThani_. Discussed taking India-Qatar bilateral ties forward. Appreciated his insights and assessments on regional developments." The two leaders had earlier held a meeting in Doha in June. The two leaders had held talks on strengthening bilateral ties across various sectors and addressing key regional challenges. Jaishankar conveyed warm greetings and wishes from Prime Minister Narendra Modi to Qatar Amir Amir, Tamim bin Hamad Al Thani, and Qatar PM. ALSO READ: ‘Approach ECI Or Courts’: Ajit Pawar Hits Back At Aaditya Thackeray Over EVM Remarks Further, he underscored the robust nature of the India-Qatar relationship, emphasising cooperation in political, trade, investment, energy, technology, culture, and people-to-people exchanges. (Except header, this copy has not been edited by Jagran English. Source: ANI)
SACRAMENTO, Calif. — California lawmakers are rushing to introduce legislation that reaffirms the state's role as a reproductive rights "haven" as President-elect Donald Trump prepares to return to the White House and abortion-rights advocates warn of an uncertain future. Abortion remains legal in California, home to the strongest reproductive rights in the nation — unlike in some states, there is no required waiting period or counseling before the procedure, and minors can get abortions without parental involvement. In 2022 , voters solidified abortion access in the state constitution after the U.S. Supreme Court overturned the federal right, limiting healthcare for millions of women. But as Trump prepares to take the White House again, California's Democratic leaders are adamant that not enough has been done to secure reproductive access in case of further federal rollbacks. "The truth is, this is an urgent and dangerous situation," California Attorney General Rob Bonta said at a news conference in Sacramento on Monday, pointing to renewed legal challenges to the distribution of abortion pills. "The right-wing extremists continue to wage attack after attack on our bodily autonomy at the expense of the health or life of pregnant persons." Bonta, a Democrat, said new legislative proposals will make reproductive rights in California "ironclad." Gov. Gavin Newsom's earlier focus on abortion rights after Trump's first term — including ad campaigns in red states — have drawn criticism from California Republicans skeptical of his national political motives and praise from advocates who say it is better to be safe than sorry. While he has signed dozens of bills firming up abortion access in recent years, some of his plans have proved to be more flash than substance. A temporary law allowing doctors licensed in Arizona to provide abortions in California, for example, expired without any doctors using it. "He makes the big pronouncements, but he's not a very good executor of those policies," said Assembly Republican leader James Gallagher of Yuba City. "It's kind of become his M.O. to make a big splash, and then nothing really ever comes of it." Democrats, however, see the need to shore up abortion access given the uncertainty of Trump's plans. A bill introduced this week aims to ensure availability of mifepristone and misoprostol — the commonly used two-step medication abortion process — even if the Trump administration attempts to interfere. At issue is how anti-abortion government officials could revive and interpret the Comstock Act , a federal law that once banned the mailing of "obscene" materials related to abortions. While Trump has said he has no plans to ban abortion nationwide, he has repeatedly flip-flopped on the issue and taken credit for appointing conservative Supreme Court justices who reversed the federal right to abortion with their decision in the landmark Dobbs case. Reproductive health advocates are worried that under his second term, the U.S. Food and Drug Administration could limit access to abortion medication. To lead the FDA, Trump has tapped Dr. Marty Makary , who has echoed antiabortion messages on Fox News about fetal pain — something disputed by major medical organizations. The California bill by former Planned Parenthood attorney and legislative newcomer Assemblymember Maggy Krell , D-Sacramento, aims to ensure that Californians continue to have access to medication abortion for the foreseeable future and protects "manufacturers, distributors, authorized healthcare providers and individuals" from any legal action for distributing or administering the pills. "There are emerging threats to the availability of mifepristone and misoprostol, and California may not be able to guarantee a continued supply," the bill states. "Previously, Governor Newsom implemented a plan to stockpile doses of misoprostol. While this effort was successful, the Legislature finds that the state needs to renew its stockpile to ensure that Californians can continue to exercise their constitutional rights." Last year, Newsom rushed to stockpile hundreds of thousands of abortion pills after a Texas judge ruled against the authorization of the medication. "We will not cave to extremists who are trying to outlaw these critical abortion services. Medication abortion remains legal in California," Newsom said then. But, facing expiration dates, the state released the stockpile to the public before the U.S. Supreme Court decision that rejected the Texas court's ruling. In Washington, Democratic Gov. Jay Inslee chose to hold onto a similar stockpile in case Trump was reelected. A spokesperson for Newsom said California "remains ready" to procure more pills if needed. In another precautionary move last year, Newsom signed a law that allowed abortion providers in Arizona to temporarily practice in California. The action came after the Arizona Supreme Court reinstated an 1800s law that essentially banned all abortions. No Arizona providers ended up using the program, which expired Dec. 1, according to the California Department of Consumer Affairs. Concerns settled in Arizona after Democratic Gov. Katie Hobbs signed a bill that repealed the court decision, and voters last month passed a state constitutional amendment guaranteeing a right to abortion . The California legislation "was designed to serve as a swift stop gap measure to preserve continued access to abortion care, if necessary, during this very precarious moment," California Department of Consumer Affairs spokesperson Monica Vargas said in an email when The Times asked for data about the program's use. Newsom also signed a law last year that allowed medical residents from states with "hostile" laws to get abortion training in California. The state does not require the California Medical Board to track whether that program is being used as intended, a spokesperson said. For Republican critics like Gallagher, those programs are instances of "political theater" meant more to draw attention to an issue than provide substantive policy. Newsom this week called a special legislative session in Sacramento to prepare for legal combat with Trump on issues such as abortion and immigration — a move heralded by liberals as smart preparation for an unpredictable president and criticized by conservatives as unnecessary panic. "In California, abortion is constitutionally protected, and you have a president-elect who has said very clearly he will not support any national abortion ban," Gallagher said. "This perceived threat that they're trying to make into a political volley ... it's just Newsom drawing attention to himself." Some abortion advocates said that they'd rather have a nimble governor like Newsom and be cautious even if the emergency plans don't always pan out. "Now more than ever is the time for innovative policy solutions," said Shannon Olivieri Hovis, a spokesperson for Essential Health Access. "And inevitably, it is going to be the case that not all solutions we put forth will be equally effective." Other bills introduced this week seeking to fill California's reproductive health access gaps include a proposal to financially penalize cities and counties that block the building of abortion clinics, as has happened in Beverly Hills and Fontana. Assemblymember Mia Bonta, D-Oakland, introduced a package of bills that ensure hospitals enforce laws that require emergency rooms to provide abortion care; make it easier for Medi-Cal recipients to get birth control; and prevent birthing centers from closing. About 40% of California counties don't have abortion clinics, including rural areas where transportation can be a hurdle. In September, the state sued a Humboldt County Catholic hospital after a patient said she was denied an emergency abortion even as she feared for her life because of miscarriage risks. "We have to be absolutely clear-eyed about the political and social moment we're in right now... when we have a proven misogynist as a president," said Mia Bonta, who is married to the attorney general, referring to Trump's sexual abuse allegations and "your body, my choice" refrains that surged after his election. "I think while California has done an amazing job, we still have a lot of work to do to shore up the infrastructure of support for people who are seeking health care and abortion access and protection of our reproductive and sexual freedoms." ©2024 Los Angeles Times. Visit latimes.com . Distributed by Tribune Content Agency, LLC.
Texas spotlights unaccompanied migrant children ahead of Trump deportation pushNone
Influencer ultraderechista Nick Fuentes enfrenta cargos por rociar a una mujer con gas lacrimógeno
Humacyte, Inc. ( NASDAQ:HUMA – Get Free Report )’s stock price was up 6% during trading on Thursday . The stock traded as high as $4.79 and last traded at $4.78. Approximately 920,995 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 2,770,237 shares. The stock had previously closed at $4.51. Analyst Upgrades and Downgrades A number of research firms have weighed in on HUMA. Benchmark boosted their price objective on Humacyte from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Monday, December 23rd. D. Boral Capital reaffirmed a “buy” rating and set a $25.00 target price on shares of Humacyte in a research note on Friday, December 20th. HC Wainwright reissued a “buy” rating and issued a $15.00 price target (up previously from $12.00) on shares of Humacyte in a research note on Friday, December 20th. BTIG Research reaffirmed a “buy” rating and set a $10.00 price target on shares of Humacyte in a research report on Friday, October 18th. Finally, TD Cowen reiterated a “buy” rating and issued a $10.00 price objective on shares of Humacyte in a research report on Friday, October 18th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $13.71. View Our Latest Report on HUMA Humacyte Price Performance Insider Buying and Selling at Humacyte In other Humacyte news, CEO Laura E. Niklason sold 811,172 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $4.44, for a total value of $3,601,603.68. Following the completion of the transaction, the chief executive officer now owns 2,419,712 shares in the company, valued at $10,743,521.28. The trade was a 25.11 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website . Also, Director Brady W. Dougan sold 427,459 shares of the stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $4.34, for a total value of $1,855,172.06. Following the completion of the sale, the director now owns 1,992,253 shares in the company, valued at approximately $8,646,378.02. The trade was a 17.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here . Insiders sold a total of 1,500,000 shares of company stock valued at $6,606,799 in the last three months. 11.20% of the stock is owned by corporate insiders. Hedge Funds Weigh In On Humacyte A number of institutional investors and hedge funds have recently made changes to their positions in HUMA. nVerses Capital LLC acquired a new stake in Humacyte in the second quarter valued at approximately $28,000. Concurrent Investment Advisors LLC purchased a new position in Humacyte in the third quarter valued at $75,000. Principal Financial Group Inc. purchased a new stake in Humacyte during the 2nd quarter worth about $83,000. FORA Capital LLC acquired a new position in shares of Humacyte during the 3rd quarter worth about $96,000. Finally, Insigneo Advisory Services LLC purchased a new position in shares of Humacyte in the 3rd quarter valued at about $109,000. 44.71% of the stock is owned by institutional investors and hedge funds. About Humacyte ( Get Free Report ) Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. Featured Stories Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter .UNICEF applauds enactment of new laws in Fiji
Cal State Fullerton’s new president, Ronald Rochon, looks to push students to successLUQUE, Paraguay (AP) — Sake is perhaps more Japanese than the world-famous sushi. It's brewed in centuries-old mountaintop warehouses, savored in the country’s pub-like izakayas, poured during weddings and served slightly chilled for special toasts. The smooth rice wine that plays a crucial role in Japan's culinary traditions was enshrined on Wednesday by UNESCO on its list of the “intangible cultural heritage of humanity." At a meeting in Luque, Paraguay, members of UNESCO’s committee for safeguarding humanity's cultural heritage voted to recognize 45 cultural practices and products around the world, including Brazilian white cheese, Caribbean cassava bread and Palestinian olive oil soap. Unlike UNESCO’s World Heritage List, which includes sites considered important to humanity like the Pyramids of Giza in Egypt, the Intangible Cultural Heritage designation names products and practices of different cultures that are deserving of recognition. A Japanese delegation welcomed the announcement in Luque. “Sake is considered a divine gift and is essential for social and cultural events in Japan,” Kano Takehiro, the Japanese ambassador to UNESCO, told The Associated Press. The basic ingredients of sake are few: rice, water, yeast and koji, a rice mold, which breaks down the starches into fermentable sugars like malting does in beer production. The whole two-monthlong process of steaming, stirring, fermenting and pressing can be grueling. The rice — which wields tremendous marketing power as part of Japan's broader cultural identity — is key to the alcoholic brew. For a product to be categorized Japanese sake, the rice must be Japanese. The UNESCO recognition, the delegation said, captured more than the craft knowledge of making high-quality sake. It also honored a tradition dating back some 1,000 years — sake makes a cameo in Japan’s famous 11th century novel, “The Tale of Genji,” as the drink of choice in the refined Heian court. Now, officials hope to restore sake's image as Japan's premier alcoholic drink even as the younger drinkers in the country switch to imported wine or domestic beer and whiskey. “It means a lot to Japan and to the Japanese,” Takehiro said of the UNESCO designation. "This will help to renew interest in traditional sake elaboration.” Also, Japanese breweries have expressed hope that the listing could give a little lift to the country's export economy as the popularity of sake booms around the world and in the United States amid heightened interest in Japanese cuisine. Sake exports, mostly to the U.S. and China, now rake in over $265 million a year, according to the Japan Sake and Shochu Makers Association, a trade group. Japan's delegation appeared ready to celebrate on Wednesday — in classic Japanese style. After the announcement, Takehiro raised a cypress box full of sake to toast the alcoholic brew and cultural rite.
- 上一篇：wolf casino game
- 下一篇：wolf casino online
